发明名称 Modulation of insulin like growth factor I receptor expression in cancer
摘要 Provided herein are methods, compounds, and compositions for reducing expression of an IGF-IR mRNA and protein in an animal. Also provided herein are methods, compounds, and compositions that inhibit expression of IGF-IR in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate the tumor or cancer, or a symptom thereof.
申请公布号 US9084770(B2) 申请公布日期 2015.07.21
申请号 US200912578471 申请日期 2009.10.13
申请人 Antisense Therapeutics, Ltd. 发明人 Tachas George;Atley Lynne Maree;Wraight Christopher J.
分类号 C12N15/113;A61K31/337;A61K31/7052 主分类号 C12N15/113
代理机构 Bozicevic, Field & Francis LLP 代理人 Francis Carol L.;Bozicevic, Field & Francis LLP
主权项 1. A method for enhancing the sensitivity of an IGF-IR positive tumor or cancer cell to a taxane based agent in a subject, the method comprising: administering to a subject having a taxane based agent-resistant, IGF-IR positive tumor or cancer cell an effective amount of an agent that inhibits expression of IGF-IR.
地址 Toorak AU